Abbott Laboratories (ABT)
$94.92+1.80%
Spriggl Score: Good— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“World-class CGM franchise with Libre Duo now CE-marked; 54-year Dividend King at a premium price demanding execution.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers …
- Sector:
- Healthcare
- Industry:
- Medical Devices
- Market Cap:
- $154.0B
Recent dividends
- 15 Jul 2026$0.63
- 15 Apr 2026$0.63
- 15 Jan 2026$0.63
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Abbott Laboratories and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free